Literature DB >> 32948912

Dark cortical rim: an MRI feature of polycystic ovarian syndrome.

Arwa Badeeb1, Alexander Brook2, Karen S Lee2.   

Abstract

PURPOSE: To determine if the presence of a dark cortical rim around the ovary on magnetic resonance imaging (MRI) is associated with polycystic ovarian syndrome (PCOS).
MATERIALS AND METHODS: This retrospective study included 52 PCOS patients with 98 total ovaries and 52 age-matched controls with 104 total ovaries. The ovaries were evaluated on MRI with at least two orthogonal views on T2-weighted sequences. Ovarian volume and follicular count per ovary were measured. Each ovary was also assessed for a dark cortical rim around the ovary on T2-weighted imaging which involved equal to or more than 50% of the ovarian circumference. The degree of rim continuity was classified as continuous if the rim involved greater than 75% of the ovarian circumference, discontinuous if 50-75% of the ovarian circumference was covered, or absent if less than 50% of the ovarian circumference was involved. The rim thickness was measured if present. T test and χ2 tests were performed to compare continuous and categorical variables, correspondingly, between cases and controls. ROC curves and area under the curve (AUC) were used to assess predictive performance and DeLong's paired test was used to compare AUCs.
RESULTS: A higher percentage of PCOS patients exhibited a continuous cortical rim about the ovary (71%) and a lower percentage of an absent cortical rim (8%) compared to controls (25% and 37%, respectively) (p < 0.001). A continuous cortical ovarian rim has a sensitivity and specificity of 71% and 75%, respectively, for diagnosing PCOS. Mean cortical rim thickness is significantly higher in the PCOS group (1.4 mm) compared with controls (0.8 mm) (p < 0.001). Cortical rim thickness and presence of a continuous cortical rim are strongly correlated. Cortical rim thickness of 1.2 mm provides a sensitivity and specificity of 75% and 60%, correspondingly, for a diagnosis of PCOS. Cortical rim thickness combined with cortical rim continuity has an AUC of 0.77 for diagnosing PCOS, which is similar to conventional imaging features of ovarian volume and follicular count combined.
CONCLUSION: A dark cortical rim around the ovary is an MRI feature that can be used to support a diagnosis of PCOS.

Entities:  

Keywords:  Cortical rim; PCOS; Polycystic ovarian syndrome; Superficial cortical fibrosis; T2 dark rim

Mesh:

Year:  2020        PMID: 32948912     DOI: 10.1007/s00261-020-02749-3

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  14 in total

1.  Long term health consequences of polycystic ovarian syndrome: a review analysis.

Authors:  A Daniilidis; K Dinas
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

2.  Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study.

Authors:  Richard Y Yoo; Claude B Sirlin; Michael Gottschalk; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2005-10       Impact factor: 7.329

Review 3.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

4.  Polycystic Ovary Syndrome in Adolescents: Which MR Imaging-based Diagnostic Criteria?

Authors:  Maxime Fondin; Antoine Rachas; Van Huynh; Stéphanie Franchi-Abella; Jean-Paul Teglas; Lise Duranteau; Catherine Adamsbaum
Journal:  Radiology       Date:  2017-07-25       Impact factor: 11.105

Review 5.  Ultrasound assessment of the polycystic ovary: international consensus definitions.

Authors:  Adam H Balen; Joop S E Laven; Seang-Lin Tan; Didier Dewailly
Journal:  Hum Reprod Update       Date:  2003 Nov-Dec       Impact factor: 15.610

6.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

7.  An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.

Authors:  Lourdes Ibáñez; Sharon E Oberfield; Selma Witchel; Richard J Auchus; R Jeffrey Chang; Ethel Codner; Preeti Dabadghao; Feyza Darendeliler; Nancy Samir Elbarbary; Alessandra Gambineri; Cecilia Garcia Rudaz; Kathleen M Hoeger; Abel López-Bermejo; Ken Ong; Alexia S Peña; Thomas Reinehr; Nicola Santoro; Manuel Tena-Sempere; Rachel Tao; Bulent O Yildiz; Haya Alkhayyat; Asma Deeb; Dipesalema Joel; Reiko Horikawa; Francis de Zegher; Peter A Lee
Journal:  Horm Res Paediatr       Date:  2017-11-13       Impact factor: 2.852

8.  Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

Authors:  Didier Dewailly; Marla E Lujan; Enrico Carmina; Marcelle I Cedars; Joop Laven; Robert J Norman; Héctor F Escobar-Morreale
Journal:  Hum Reprod Update       Date:  2013-12-16       Impact factor: 15.610

9.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Authors:  Neil F Goodman; Rhoda H Cobin; Walter Futterweit; Jennifer S Glueck; Richard S Legro; Enrico Carmina
Journal:  Endocr Pract       Date:  2015-11       Impact factor: 3.443

10.  Polycystic ovaries: MR imaging.

Authors:  D G Mitchell; W B Gefter; C E Spritzer; L Blasco; J Nulson; V Livolsi; L Axel; P H Arger; H Y Kressel
Journal:  Radiology       Date:  1986-08       Impact factor: 11.105

View more
  1 in total

1.  Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review.

Authors:  Xuechun Bai; Lianwen Zheng; Dandan Li; Ying Xu
Journal:  Reprod Biol Endocrinol       Date:  2021-08-06       Impact factor: 5.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.